01/25/2025 | Press release | Distributed by Public on 01/25/2025 12:11
Preliminary Results From a Randomized, Open-Label, Phase 2 Study of BotensilimabWith or Without Balstilimabin Refractory Microsatellite Stable Metastatic Colorectal Cancer With[...]
